EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Seroprevalence of SARS‐CoV‐2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon

René Ghislain Essomba, Albert Ngano Bayibeki, Abel Lissom, Pulchérie Thérèse Ateba, Nassif Seni, Claude Ariane Nlozoa Fouda, Solange Berthe Diwandja Mbitock, Normand David Ebonda, Sylvie Delphine Afana, Siméon Akame, Adelphe Anyang Tembu, Modeste Romuald Ngamaleu und 14 weitere

Influenza and Other Respiratory Viruses · 2023

DOI: 10.1111/irv.13222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Influenza and Other Respiratory Viruses, 2023. Verfasst von René Ghislain Essomba und 25 weiteren Autor:innen. Beteiligte Einrichtung: National Public Health Laboratory (NPHL) Ministry of Public Health Yaoundé Cameroon. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The COVID‐19 pandemic has caused a public health emergency in all sectors of society, including universities and other academic institutions in Cameroon. However, little is known concerning the real prevalence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections among student communities during the second wave of infection in Cameroon. This study aimed to estimate SARS‐CoV‐2 antibodies seroprevalence among participants in a university community in Cameroon. Methodology A cross‐sectional study was conducted from March to April 2021 in 547 students aged ≥18 years during a mass diagnostic campaign at the School of Health Sciences of the Catholic University of Central Africa (ESS/UCAC). The anti‐SARS‐CoV‐2 antibody screening was done using the Panbio™ COVID‐19 IgG/IgM Rapid Diagnostic Test.

Results

The overall seroprevalence of SARS‐CoV‐2 antibodies was 27%, of which 89.9% ( n = 133) was IgG, 6.7% ( n = 10) IgM and 3.4% ( n = 5) IgG/IgM positive. The undergraduate students represented 79% (432/547) of the total population and were highly positive with anti‐SARS‐CoV‐2 antibodies 30% (130/432) as compared with postgraduate students 20% (23/115). The total antibody seropositivity was higher in males (34.4%) than females (24.9%). Several factors were associated with an increased risk of SARS‐CoV‐2 seroprevalence including the male gender (OR: 1.61 [95% confidence interval, CI 1.0–2.4]), specialization to medical laboratory (OR: 2.8 [95% CI 1.1–7.1]) and nursing sciences (OR: 2.6 [95% CI 1.1–6.2]).

Conclusion

Our findings point to extensive and underreported circulation of SARS‐CoV‐2 in a university community during the second wave of infection in Cameroon, which likely resulted in artificially low case counts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19FemaleHumansMaleAdolescentAdultUniversitiesCameroonCross-Sectional StudiesPandemicsSeroepidemiologic StudiesAntibodies, ViralRisk FactorsImmunoglobulin GImmunoglobulin M

Stichwörter der Autor:innen

COVID‐19CameroonSARS‐CoV‐2rapid diagnostic testseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • National Public Health Laboratory (NPHL) Ministry of Public Health Yaoundé Cameroon.
  • Faculty of Medicine and Biomedical Sciences (FMBS) University of Yaoundé I Yaoundé Cameroon.
  • School of Health Sciences Catholic University of Central Africa (ESS-UCAC) Yaoundé Cameroon.
  • National Public Health Emergency Operations Coordination Centre (NPHEOCC) Ministry of Public Health Yaoundé Cameroon.
  • Department of Zoology, Faculty of Sciences University of Bamenda (UBa) Bamenda Cameroon.
  • Higher Institute of Sciences and Techniques Applied to Health, Faculty of Medicine and Pharmaceutical Sciences University of Douala Yaoundé Cameroon.

Zitieren

APA

Essomba, R. G., Bayibeki, A. N., Lissom, A., Ateba, P. T., Seni, N., Fouda, C. A. N., Mbitock, S. B. D., Ebonda, N. D., Afana, S. D., Akame, S., Tembu, A. A., Ngamaleu, M. R., Bimai, B. C. B., Kabo, O., Nguwoh, P. S., Ngounouh, C. T., Meka, M. C. J., Kengne, M., Likeng, J. N., …, & Chadou, M. J. P. (2023). Seroprevalence of SARS‐CoV‐2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.13222

Vancouver

Essomba RG, Bayibeki AN, Lissom A, Ateba PT, Seni N, Fouda CAN, et al. Seroprevalence of SARS‐CoV‐2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon. Influenza and Other Respiratory Viruses. 2023. doi:10.1111/irv.13222

BibTeX
@article{Essomba2023,
  author = {Essomba, René Ghislain and Bayibeki, Albert Ngano and Lissom, Abel and Ateba, Pulchérie Thérèse and Seni, Nassif and Fouda, Claude Ariane Nlozoa and Mbitock, Solange Berthe Diwandja and Ebonda, Normand David and Afana, Sylvie Delphine and Akame, Siméon and Tembu, Adelphe Anyang and Ngamaleu, Modeste Romuald and Bimai, Bernard Christel Bihonba and Kabo, Ousmane and Nguwoh, Philipe Salomon and Ngounouh, Christian Taheu and Meka, Moise Christian Junior and Kengne, Michel and Likeng, Julienne-Louise Ngo and Kimessoukie, Etienne Omolomo and Nkoum, Benjamin Alexandre and Assoumou, Marie Claire Okomo and Fokam, Joseph and Yap Boum, I I and Ambomo, Myriam Sylvie and Chadou, Michael Junior Piameu},
  title = {Seroprevalence of SARS‐CoV‐2 antibodies and associated risk factors during the second wave of infection in a university community in Cameroon},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2023},
  doi = {10.1111/irv.13222}
}
Kostenlos starten →